205 related articles for article (PubMed ID: 36991386)
1. Development and validation of an online dynamic nomogram based on the atherogenic index of plasma to screen nonalcoholic fatty liver disease.
Peng H; Zhang J; Huang X; Xu M; Huang J; Wu Y; Peng XE
Lipids Health Dis; 2023 Mar; 22(1):44. PubMed ID: 36991386
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
[TBL] [Abstract][Full Text] [Related]
3. Validation of nonalcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD.
Chen J; Mao X; Deng M; Luo G
Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):394-401. PubMed ID: 36695773
[TBL] [Abstract][Full Text] [Related]
4. A clinical and laboratory-based nomogram for predicting nonalcoholic fatty liver disease in non-diabetic adults: a cross-sectional study.
Qian Y; Sun B; Zhang Y; Zhang M; Jiao X; Lai L; Yang W
Ann Palliat Med; 2022 Jul; 11(7):2349-2359. PubMed ID: 35542976
[TBL] [Abstract][Full Text] [Related]
5. Nomogram for predicting the risk of nonalcoholic fatty liver disease in older adults in Qingdao, China: A cross-sectional study.
Wang Z; Cui J; Li X; Gao R; Feng E; Luo G; Guo B; Wu H; Sun Y; Sun J
Asia Pac J Clin Nutr; 2024 Mar; 33(1):83-93. PubMed ID: 38494690
[TBL] [Abstract][Full Text] [Related]
6. A Prediction Model Based on Noninvasive Indicators to Predict the 8-Year Incidence of Type 2 Diabetes in Patients with Nonalcoholic Fatty Liver Disease: A Population-Based Retrospective Cohort Study.
Cai X; Zhu Q; Cao Y; Liu S; Wang M; Wu T; Hong J; Ahmat A; Aierken X; Li N
Biomed Res Int; 2021; 2021():5527460. PubMed ID: 34095297
[TBL] [Abstract][Full Text] [Related]
7. Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogram.
Zhou YJ; Ye FZ; Li YY; Pan XY; Chen YX; Wu XX; Xiong JJ; Liu WY; Xu SH; Chen YP; Zheng MH
United European Gastroenterol J; 2019 Oct; 7(8):1124-1134. PubMed ID: 31662869
[TBL] [Abstract][Full Text] [Related]
8. SFI, a sex hormone binding globulin based nomogram for predicting non-alcoholic fatty liver disease in the Chinese population.
Hua X; Zhang H; Yang W; Liu G; Zhang S; Wang Y
Front Endocrinol (Lausanne); 2023; 14():1176019. PubMed ID: 37334312
[TBL] [Abstract][Full Text] [Related]
9. A nomogram incorporated lifestyle indicators for predicting nonalcoholic fatty liver disease.
Peng K; Wang S; Gao L; You H
Medicine (Baltimore); 2021 Jul; 100(26):e26415. PubMed ID: 34190160
[TBL] [Abstract][Full Text] [Related]
10. Validity of fatty liver prediction scores for diagnosis of fatty liver by Fibroscan.
Jeong S; Park SJ; Na SK; Park SM; Song BC; Oh YH
Hepatobiliary Pancreat Dis Int; 2024 Aug; 23(4):353-360. PubMed ID: 36870896
[TBL] [Abstract][Full Text] [Related]
11. A nomogram for discrimination of non-alcoholic fatty liver disease in patients with chronic hepatitis B.
Chen Y; Cao D; Li C; Zhang P; Wang X; Li N; Han Q; Liu Z
Eur J Gastroenterol Hepatol; 2021 Jan; 33(1):69-75. PubMed ID: 32118853
[TBL] [Abstract][Full Text] [Related]
12. A Prediction Model of the Incidence of Nonalcoholic Fatty Liver Disease With Visceral Fatty Obesity: A General Population-Based Study.
Zhou Y; Chai X; Guo T; Pu Y; Zeng M; Zhong A; Yang G; Cai J
Front Public Health; 2022; 10():895045. PubMed ID: 35812496
[TBL] [Abstract][Full Text] [Related]
13. Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome.
Chen LD; Huang JF; Chen QS; Lin GF; Zeng HX; Lin XF; Lin XJ; Lin L; Lin QC
Chin Med J (Engl); 2019 Nov; 132(22):2670-2676. PubMed ID: 31765354
[TBL] [Abstract][Full Text] [Related]
14. Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease.
Liu WY; Zheng KI; Pan XY; Ma HL; Zhu PW; Wu XX; Rios RS; Targher G; Byrne CD; Wang XD; Chen YP; Zheng MH
J Gastroenterol Hepatol; 2020 Jun; 35(6):1057-1064. PubMed ID: 31677195
[TBL] [Abstract][Full Text] [Related]
15. Validation of five hepatic steatosis algorithms in metabolic-associated fatty liver disease: A population based study.
Liu Y; Liu S; Huang J; Zhu Y; Lin S
J Gastroenterol Hepatol; 2022 May; 37(5):938-945. PubMed ID: 35174539
[TBL] [Abstract][Full Text] [Related]
16. Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease.
McHenry S; Tirath A; Tsai R; Sharma Y; Flores AG; Davidson NO; Fowler KJ; Ciorba MA; Deepak P
Inflamm Bowel Dis; 2020 Nov; 26(12):1917-1925. PubMed ID: 31907542
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese.
Huang X; Xu M; Chen Y; Peng K; Huang Y; Wang P; Ding L; Lin L; Xu Y; Chen Y; Lu J; Wang W; Bi Y; Ning G
Medicine (Baltimore); 2015 Oct; 94(40):e1682. PubMed ID: 26448014
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study.
Pan H; Liu B; Luo X; Shen X; Sun J; Zhang A
Lipids Health Dis; 2023 Nov; 22(1):205. PubMed ID: 38007441
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and prediction model for nonalcoholic fatty liver disease in northwest China.
Li D; Zhang M; Wu S; Tan H; Li N
Sci Rep; 2022 Aug; 12(1):13877. PubMed ID: 35974018
[TBL] [Abstract][Full Text] [Related]
20. Development and application of a novel model to predict the risk of non-alcoholic fatty liver disease among lean pre-diabetics with normal blood lipid levels.
Zhu W; Shi P; Fu J; Liang A; Zheng T; Wu X; Yuan S
Lipids Health Dis; 2022 Dec; 21(1):149. PubMed ID: 36585668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
